Allergy & Asthma Medical Group & Research is categorized under Allergists in Encinitas, CA .
Allergy & Asthma Medical Group & Research was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Allergists business, which does work in the B2C market, and is classified as a Allergists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Linda Clarke at the company’s single location by writing to 317 North El Camino Real # 501, Encinitas, California CA 92024 or by phoning (760) 944-6377. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Allergy & Asthma Medical Group & Research |
| Contact Person: | Linda Clarke |
| Address: | 317 North El Camino Real # 501, Encinitas, California 92024 |
| Phone Number: | (760) 944-6377 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Allergists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Allergy & Asthma Medical Group & Research was started in 0 to provide professional Allergists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Linda Clarke for inquiries that concern Allergy & Asthma Medical Group & Research by calling the company number (760) 944-6377, as your correspondence is most welcome. Additionally, the physical location of the single location of Allergy & Asthma Medical Group & Research can be found at the coordinates as well as the street address 317 North El Camino Real # 501 in Encinitas, California 92024.
For its online presence, you may visit Allergy & Asthma Medical Group & Research’s website at and engage with its social media outlets through on Twitter and on Facebook.